There are currently no events to display.
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain.
ACRX (Common Stock)
Data provided by Nasdaq. Minimum 15 minutes delayed.
05/24/18May242018 Summary ToggleAcelRx announces FDA acceptance of NDA for DSUVIA
05/23/18May232018 Summary ToggleThree Arch's shares of AcelRx common stock acquired in a private transaction led by Leerink Revelation Partners and Industry Ventures
05/22/18May222018 Summary ToggleAcelRx Pharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference
March 2018 Corporate Presentation